CanBas Co., Ltd. (TYO:4575)
Japan · Delayed Price · Currency is JPY 736.00
0.00 (0.00%)
Oct 26, 2026, 3:30 PM JST
CanBas Market Cap
CanBas has a market cap or net worth of 14.07 billion as of October 26, 2026. It is the 25,903rd most valuable company in the world and the 2,237th biggest in Japan. Its market cap has decreased by 26.98% in one year.
Market Cap
14.07B
Enterprise Value
12.62B
Revenue
n/a
Global Rank
Country Rank
#2,237 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 18, 2009, CanBas's market cap has increased from 8.38B to 14.07B, an increase of 67.80%. That is a compound annual growth rate of 3.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 14.07B | -8.34% |
| Dec 30, 2025 | 15.35B | -10.38% |
| Dec 30, 2024 | 17.13B | 0.65% |
| Dec 29, 2023 | 17.01B | -5.30% |
| Dec 30, 2022 | 17.97B | 974.22% |
| Dec 30, 2021 | 1.67B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovacell | 20.45B |
| RaQualia Pharma | 15.72B |
| Stella Pharma | 14.96B |
| ReproCELL | 12.67B |
| AnGes | 11.17B |
| Immuno-Biological Laboratories | 9.47B |
| Kubota Pharmaceutical Holdings | 9.40B |
| StemRIM | 9.09B |